SAN DIEGO, CA / ACCESS Newswire / August 26, 2025 / Modular Medical, Inc. (Nasdaq:MODD) ("Modular Medical" or the "Company"), an insulin delivery technology company with the first FDA-cleared patch ...

Modular Medical, Inc. (Nasdaq: MODD) is a development-stage medical device company that intends to launch the next generation of insulin delivery technology. Using its patented technologies, the ...

SAN DIEGO, CA / ACCESS Newswire / August 6, 2025 / Modular Medical, Inc. (Nasdaq:MODD) ("Modular Medical" or the "Company"), an insulin delivery technology company with the first FDA-cleared patch ...

-Line has been in production at risk since early July - Production to continue until late August when conversion to Pivot manufacturing will begin SAN DIEGO, CA / ACCESS Newswire / August 4, 2025 / ...

SAN DIEGO - Modular Medical, Inc. (NASDAQ:MODD), a medical device company with a market capitalization of $38.22 million and currently trading at $0.70 per share, announced Thursday it has completed a ...

-Proof of Concept Study in Rapid Acting GLP-1 to commence in October 2024 with data expected in November 2024 -Pre-clinical study to explore use of MODD1 pump as a personalized delivery system for ...

SAN DIEGO, CA / ACCESSWIRE / January 19, 2024 / Modular Medical, Inc. (NASDAQ:MODD) ("Modular Medical" or the "Company"), a development-stage, insulin delivery technology company seeking to launch the ...

- Conversion to Pivot-ready manufacturing in preparation for product launch in 1Q26 SAN DIEGO, CA / ACCESS Newswire / August 26, 2025 / Modular Medical, Inc. (Nasdaq:MODD) ("Modular Medical" or the ...

SAN DIEGO, CA / ACCESS Newswire / August 4, 2025 / Modular Medical, Inc. (Nasdaq:MODD) ("Modular Medical" or the "Company"), an insulin delivery technology company with the first FDA-cleared patch ...